0001543084-16-000004.txt : 20160705
0001543084-16-000004.hdr.sgml : 20160705
20160705110844
ACCESSION NUMBER: 0001543084-16-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160630
FILED AS OF DATE: 20160705
DATE AS OF CHANGE: 20160705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: van Deventer Sander
CENTRAL INDEX KEY: 0001543084
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 161749220
MAIL ADDRESS:
STREET 1: POSTBUS 5187
CITY: NAARDEN
STATE: P7
ZIP: 1410 AD
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-06-30
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001543084
van Deventer Sander
POSTBUS 5187
NAARDEN
P7
1410 AD
NETHERLANDS
1
0
1
0
Common Stock
2016-06-30
4
A
0
1427
0
A
2794
D
The reporting person has received a fully vested stock award for shares of the Company's common stock. For calendar year 2016, the Company has elected to make common stock awards in lieu of cash payments of director fees otherwise payable under the director compensation policy. The number of shares of common stock awarded represent the quotient of (A) such director fees divided by (B) the Company's closing stock price on the date awarded, rounded down to the nearest whole share of common stock.
/s/ Lori R. Harrelson, attorney-in-fact
2016-07-05